Cargando…
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995917/ https://www.ncbi.nlm.nih.gov/pubmed/35411106 http://dx.doi.org/10.1038/s41409-022-01664-z |
| _version_ | 1784684387505274880 |
|---|---|
| author | Borogovac, Azra Keruakous, Amany Bycko, Michelle Holter Chakrabarty, Jennifer Ibrahimi, Sami Khawandanah, Mohamad Selby, George B. Yuen, Carrie Schmidt, Sarah Autry, Marcus T. Al-Juhaishi, Taha Wieduwilt, Matthew J. Asch, Adam S. |
| author_facet | Borogovac, Azra Keruakous, Amany Bycko, Michelle Holter Chakrabarty, Jennifer Ibrahimi, Sami Khawandanah, Mohamad Selby, George B. Yuen, Carrie Schmidt, Sarah Autry, Marcus T. Al-Juhaishi, Taha Wieduwilt, Matthew J. Asch, Adam S. |
| author_sort | Borogovac, Azra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8995917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89959172022-04-11 Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center Borogovac, Azra Keruakous, Amany Bycko, Michelle Holter Chakrabarty, Jennifer Ibrahimi, Sami Khawandanah, Mohamad Selby, George B. Yuen, Carrie Schmidt, Sarah Autry, Marcus T. Al-Juhaishi, Taha Wieduwilt, Matthew J. Asch, Adam S. Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-04-11 2022 /pmc/articles/PMC8995917/ /pubmed/35411106 http://dx.doi.org/10.1038/s41409-022-01664-z Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Borogovac, Azra Keruakous, Amany Bycko, Michelle Holter Chakrabarty, Jennifer Ibrahimi, Sami Khawandanah, Mohamad Selby, George B. Yuen, Carrie Schmidt, Sarah Autry, Marcus T. Al-Juhaishi, Taha Wieduwilt, Matthew J. Asch, Adam S. Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center |
| title | Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center |
| title_full | Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center |
| title_fullStr | Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center |
| title_full_unstemmed | Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center |
| title_short | Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center |
| title_sort | safety and feasibility of outpatient chimeric antigen receptor (car) t-cell therapy: experience from a tertiary care center |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995917/ https://www.ncbi.nlm.nih.gov/pubmed/35411106 http://dx.doi.org/10.1038/s41409-022-01664-z |
| work_keys_str_mv | AT borogovacazra safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT keruakousamany safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT byckomichelle safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT holterchakrabartyjennifer safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT ibrahimisami safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT khawandanahmohamad safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT selbygeorgeb safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT yuencarrie safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT schmidtsarah safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT autrymarcust safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT aljuhaishitaha safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT wieduwiltmatthewj safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter AT aschadams safetyandfeasibilityofoutpatientchimericantigenreceptorcartcelltherapyexperiencefromatertiarycarecenter |